Opportunity ID: 56103

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AI-10-019
Funding Opportunity Title: Genomics of Transplantation Cooperative Research Program (U01, U19)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy, Immunology and Transplantation Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jul 23, 2010
Last Updated Date:
Original Closing Date for Applications: Nov 19, 2010
Current Closing Date for Applications: Nov 19, 2010
Archive Date: Dec 20, 2010
Estimated Total Program Funding: $4,000,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
Small businesses
Native American tribal governments (Federally recognized)
Independent school districts
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
City or township governments
County governments
Special district governments
State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
For profit organizations other than small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: Purpose. The National Institute of Allergy and Infectious Diseases (NIAID) invites new or renewal applications from single institutions or consortia of institutions to participate in a cooperative interdisciplinary research program for large-scale, broad-scope genomic studies in clinical transplantation of solid organ, tissue, and cells. The goals of this program are to identify and characterize gene polymorphisms and gene expression patterns that: (1) correlate with and/or predict transplantation outcomes; (2) define immune responses relating to the onset and severity of acute and chronic graft rejection; (3) predict responses to immunosuppression to allow tailoring of therapy; and (4) elucidate the genetic basis of variability in graft survival between populations or individuals. The long-term goal of the program is to understand the genetic basis of immune-mediated graft rejection and differences in transplant outcomes to provide a rational basis for developing more effective treatments to improve long-term graft survival and provide a better quality-of-life for transplant patients.
Mechanism of Support. This Funding Opportunity Announcement (FOA) will utilize the single project (U01), and multi-project (U19) Cooperative Agreement award mechanism.
Funds Available and Anticipated Number of Awards. The NIAID anticipates that approximately $4 million total costs will be available in FY 2011 to fund two to four new or renewal U01 and/or U19 awards.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-10-019.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

2025-07-12T03:10:33-05:00

Share This Post, Choose Your Platform!

About the Author: